Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.23, Iss.5, 2003-01, pp. : 323-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Delavirdine and N -Delavirdine in HIV-Infected Individuals

By Patrick F. Smith Robert DiCenzo

Clinical Pharmacokinetics, Vol. 44, Iss. 1, 2005-01 ,pp. : 99-109

Adis International

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Apricitabine, a Novel Nucleoside Reverse Transcriptase Inhibitor, in Patients with HIV-1 Infection

By Cahn Pedro

Clinical Drug Investigation, Vol. 28, Iss. 2, 2008-01 ,pp. : 129-138

Adis International

Access to resources Recommend Favorite

Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients

By Sriwiriyajan Somchai Mahatthanatrakul Werawath Ridtitid Wibool Jaruratanasirikul Sutep

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

By Millán Olga

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 525-538

Adis International

Access to resources Recommend Favorite

Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection

By Morse G.D.

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite